Cardiotoxicity induced by tyrosine kinase inhibitors

Brain natriuretic peptide level as marker of cardiac function in imatinib—Treated chronic myeloid leukemia patients: No evidence of cardiotoxicity of imatinib therapy

(2008) Mario Tiribelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

(2008) M. L. Telli et al.   ANNALS OF ONCOLOGY

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

(2008) A A M van der Veldt et al.   BRITISH JOURNAL OF CANCER

Heart failure associated with sunitinib malate

(2008) Aarif Y. Khakoo et al.   CANCER

Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

(2008) Manuela Schmidinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity

(2007) P. J. Perik et al.   ANNALS OF ONCOLOGY